Schwameis Richard (Richard Schwameis)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Sentinel Lymph Node

Radiation Therapy

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Scientific reports

Journal of gynecologic oncology

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Gaillard, Schwameis Richard, Enora Laas-Faron, Tali Eisenberg-Nissim, Xavier Matias-Guiu, Carien L Creutzberg, Jonathan A Ledermann, François Planchamp, Nicole Concin
An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Schwameis Richard, Luis Chiva de Agustín, Philipp Harter
There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 32 (4) (2022)
Thomas Bartl, Christine Bekos, Magdalena Postl, Reinthaller Alexander, Stephan Polterauer, Stefanie Aust, Schwameis Richard
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer. Journal of gynecologic oncology 32 (1) (2020)
Schwameis Richard, Magdalena Postl, Christine Bekos, Lukas Hefler, Alexander Reinthaller, Veronika Seebacher, Christoph Grimm, Stephan Polterauer, Samir Helmy-Bader
Prognostic value of serum creatine level in patients with vulvar cancer. Scientific reports 9 (1) (2019)
Nina Poetsch, Alina Sturdza, Stefanie Aust, Stephan Polterauer, Christoph Grimm, Schwameis Richard, Richard Pötter, Heinz Koelbl, Reinthaller Alexander, Veronika Seebacher
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 195 (5) (2019)